Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 43, 2011, Pages 17690-17695

  Freire de Lima, Leonardo ^a   Gelfenbeyn, Kirill ^a   Ding, Yao ^a   Mandel, Ulla ^b   Clausen, Henrik ^b   Handa, Kazuko ^a   Hakomori, Sen Itiroh ^a,c  

^a PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

O glycosylated fibronectin; siRNA

Indexed keywords

EPITOPE; FIBRONECTIN; GLYCAN; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY FDC6; MUCIN; ONCOFETAL FIBRONECTIN; THREONINE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER TISSUE; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FETUS CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CADHERINS; CELL LINE; DNA PRIMERS; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLYCOSYLATION; HUMANS; MICE; N-ACETYLGALACTOSAMINYLTRANSFERASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 80055097459     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1115191108     Document Type: Article

References (59)

1. Haltiwanger RS, Lowe JB (2004) Role of glycosylation in development. Annu Rev Biochem 73:491-537. (Pubitemid 39050378)
2. Hakomori S (2000) Traveling for the glycosphingolipid path. Glycoconj J 17:627-647.
3. Miljan EA, Bremer EG (2002) Regulation of growth factor receptors by gangliosides. Science STKE 2002:11-10 RE15.
4. Rebbaa A, Chou PM, Bremer EG (2004) Modulation of Growth Factor response in brain tumors by complex carbohydrates. Bull Cancer 91:E15-E60.
5. Todeschini AR, Dos Santos JN, Handa K, Hakomori SI (2007) Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem 282:8123-8133. (Pubitemid 47093583)
6. Stanley P (2007) Regulation of Notch signaling by glycosylation. Curr Opin Struct Biol 17:530-535.
7. Brückner K, Perez L, Clausen H, Cohen S (2000) Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature 406:411-415. (Pubitemid 30625560)
8. Moloney DJ, et al. (2000) Fringe is a glycosyltransferase that modifies Notch. Nature 406:369-375. (Pubitemid 30625549)
9. Hay ED (2005) The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233:706-720.
10. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890.
11. Lee JM, Dedhar S, Kalluri R, Thompson EW (2006) The epithelial- mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 172:973-981.
12. Weinberg RA (2008) Mechanisms of malignant progression. Carcinogenesis 29:1092-1095.
13. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142. (Pubitemid 43278296)
14. Hugo H, et al. (2007) Epithelial - mesenchymal and mesenchymal - epithelial transitions in carcinoma progression. J Cell Physiol 213:374-383. (Pubitemid 47509716)
15. Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776-1784. (Pubitemid 38063698)
16. Guan F, Handa K, Hakomori SI (2009) Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc Natl Acad Sci USA 106:7461-7466.
17. Guan F, Schaffer L, Handa K, Hakomori SI (2010) Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-beta. FASEB J 24:4889-4903.
18. White ES, Muro AF (2011) Fibronectin splice variants: Understanding their multiple roles in health and disease using engineered mouse models. IUBMB Life 63:538-546.
19. White ES, Baralle FE, Muro AF (2008) New insights into form and function of fibronectin splice variants. J Pathol 216:1-14.
20. Pankov R, Yamada KM (2002) Fibronectin at a glance. J Cell Sci 115:3861-3863. (Pubitemid 35256486)
21. Zardi L, et al. (1987) Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J 6:2337-2342.
22. Matsuura H, Hakomori S (1985) The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: Its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci USA 82:6517-6521. (Pubitemid 16230545)
23. Matsuura H, et al. (1988) The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide. J Biol Chem 263:3314-3322. (Pubitemid 18072789)
24. Schachter H, Brockhausen I (1992) Glycoconjugates: Composition, Structure, and Function, eds Allen H, Kisailus E (Marcel Dekker, New York), pp 263-332.
25. Matsuura H, Greene T, Hakomori S (1989) An alpha-N- acetylgalactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin. J Biol Chem 264:10472-10476. (Pubitemid 19161611)
26. Tarp MA, et al. (2007) Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat. Glycobiology 17:197-209. (Pubitemid 46152536)
27. Bennett EP, Hassan H, Clausen H (1996) cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N- acetylgalactosaminyltransferase, GalNAc-t3. J Biol Chem 271:17006-17012. (Pubitemid 26244245)
28. Bennett EP, et al. (1999) Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy. J Biol Chem 274:25362-25370.
29. Wandall HH, et al. (2007) Molecular basis for the presence of glycosylated onco-foetal fibronectin in oral carcinomas: The production of glycosylated onco-foetal fibronectin by carcinoma cells. Oral Oncol 43:301-309. (Pubitemid 46228006)
30. Kong D, et al. (2010) Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS ONE 5:e12445.
31. Marian CO, et al. (2011) Evidence of epithelial to mesenchymal transition associated with increased tumorigenic potential in an immortalized normal prostate epithelial cell line. Prostate 71:626-636.
32. Lee L, Abe A, Shayman JA (1999) Improved inhibitors of glucosylceramide synthase. J Biol Chem 274:14662-14669.
33. Wandall HH, et al. (1997) Substrate specificities of three members of the human UDPN-acetyl-alpha-D-galactosamine:Polypeptide N- acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J Biol Chem 272:23503-23514. (Pubitemid 27410917)
34. Kilian O, et al. (2004) Expression of EDA+ and EDB+ fibronectin splice variants in bone. Bone 35:1334-1345. (Pubitemid 40260396)
35. Kuan SF, Byrd JC, Basbaum C, Kim YS (1989) Inhibition of mucin glycosylation by aryl-N-acetyl- alpha-galactosaminides in human colon cancer cells. J Biol Chem264:19271-19277. (Pubitemid 19285840)
36. Sugrue SP, Hay ED (1981) Response of basal epithelial cell surface and cytoskeleton to solubilized extracellular matrix molecules. J Cell Biol 91:45-54. (Pubitemid 12252763)
37. Hakomori S (1984) Tumor-associated carbohydrate antigens. Annu Rev Immunol 2:103-126.
38. Hakomori S (1996) Tumor malignancy defined by aberrant glycosylation and sphingo (glyco)lipid metabolism. Cancer Res 56:5309-5318.
39. Hakomori S (2002) Glycosylation defining cancer malignancy: New wine in an old bottle. Proc Natl Acad Sci USA 99:10231-10233.
40. Varki A, Kannagi R, Toole BP (2009) Glycosylation changes in cancer. Essentials of Glycobiology, eds Varki A, et al. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY), 2nd Ed, pp 617-632.
41. Gahmberg CG, Hakomori S (1975) Surface carbohydrates of hamster fibroblasts. I. Chemical characterization of surface-labeled glycosphingolipids and aspecific ceramide tetrasaccharide for transformants. J Biol Chem 250:2438-2446.
42. Nudelman ED, Levery SB, Igarashi Y, Hakomori S (1992) Plasmalopsychosine, a novel plasmal (fatty aldehyde) conjugate of psychosine with cyclic acetal linkage. Isolation and characterization from human brain white matter. J Biol Chem 267:11007-11016.
43. Ledeen RW, Yu RK, Eng LF (1973) Gangliosides of human myelin: Sialosylgalactosylceramide (G7) as a major component. J Neurochem 21:829-839.
44. Turley EA, Veiseh M, Radisky DC, Bissell MJ (2008) Mechanisms of disease: Epithelialmesenchymal transition - does cellular plasticity fuel neoplastic progression? Nat Clin Pract Oncol 5:280-290. (Pubitemid 351594144)
45. Barnett P, et al. (2011) Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells. Biochem Biophys Res Commun 404:34-39.
46. Gan Y, et al. (2010) Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene 29:4947-4958.
47. Wallerand H, et al. (2010) The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers. Urol Oncol 28:473-479.
48. Jiang YG, et al. (2007) Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. Int J Urol 14:1034-1039.
49. Hakomori S, et al. (1984) Extracellular matric biochemistry, eds Piez KA, Reddi AH (Elsevier, New York), pp 230-275.
50. Fukuda M, Hakomori S (1979) Carbohydrate structure of galactoprotein a, a major transformation-sensitive glycoprotein released from hamster embryo fibroblasts. J Biol Chem 254:5451-5457. (Pubitemid 9231910)
51. Murayama K, et al. (1984) The carbohydrate structure of human fibronectins: A comparison between normal embryonic lung fibroblasts WI-38 and the SV40 virus transformed cell line VA13. Glycoconj J 1:155-169. (Pubitemid 15234840)
52. Sekiguchi K, Siri A, Zardi L, Hakomori S (1985) Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domain-specific antibodies. J Biol Chem 260:5105-5114. (Pubitemid 15031513)
53. Borsi L, et al. (1987) Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J Cell Biol 104:595-600. (Pubitemid 17024714)
54. Borsi L, Balza E, Allemanni G, Zardi L (1992) Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues. Exp Cell Res 199:98-105.
55. Moustakas A, Heldin CH (2007) Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98:1512-1520. (Pubitemid 47308444)
56. Hynes RO (1992) Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25.
57. Kim KK, et al. (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 103:13180-13185. (Pubitemid 44338936)
58. Câmara J, Jarai G (2010) Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. Fibrogenesis Tissue Repair 3:2.
59. Park JH, Katagiri T, Chung S, Kijima K, Nakamura Y (2011) Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin. Neoplasia 13:320-326.